We are live on ! Find out more
ARNA

Arena Pharmaceuticals Inc
ARNA

Delisted

ARNA was delisted on the 10th of March, 2022.

Back to rankings

1 hedge funds and large institutions have $0 invested in Arena Pharmaceuticals Inc in 2022 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 312 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 316 → 1 (-315)

100% less funds holding in top 10

Funds holding in top 10: 7 → 0 (-7)

100% less capital invested

Capital invested by funds: $4.86B → $0 (-$4.86B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 312

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
1
Holders Change
-315
Holders Change %
-99.68%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
-7
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
1
Closed
312
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$530M
2
BlackRock
BlackRock
New York
-$452M
3
Wellington Management Group
Wellington Management Group
Massachusetts
-$361M
4
State Street
State Street
Massachusetts
-$213M
5
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$167M
Name Holding Trade Value Shares
Change 		Change in
Stake
EAM
151
Erste Asset Management
Austria
– -$2.39M -25,700 Closed
AAM
152
Advisors Asset Management
Colorado
– -$2.39M -25,680 Closed
State Board of Administration of Florida Retirement System
153
State Board of Administration of Florida Retirement System
Florida
– -$2.31M -24,811 Closed
HA
154
Havens Advisors
New York
– -$2.28M -24,500 Closed
PVI
155
Pura Vida Investments
New York
– -$2.26M -24,361 Closed
HighTower Advisors
156
HighTower Advisors
Illinois
– -$2.26M -24,283 Closed
Walleye Capital
157
Walleye Capital
New York
– -$2.25M -24,197 Closed
Victory Capital Management
158
Victory Capital Management
Texas
– -$2.22M -23,893 Closed
VOYA Investment Management
159
VOYA Investment Management
Georgia
– -$2.21M -23,794 Closed
Allspring Global Investments
160
Allspring Global Investments
North Carolina
– -$2.17M -23,327 Closed
CIM
161
Cambria Investment Management
California
– -$2.15M -23,160 Closed
HSBC Holdings
162
HSBC Holdings
United Kingdom
– -$2.15M -23,089 Closed
T. Rowe Price Associates
163
T. Rowe Price Associates
Maryland
– -$2.11M -22,659 Closed
ProShare Advisors
164
ProShare Advisors
Maryland
– -$2.06M -22,148 Closed
BC
165
Birchview Capital
Vermont
– -$2.04M -22,000 Closed
GI
166
GAMCO Investors
Connecticut
– -$2.04M -22,000 Closed
HS
167
HighVista Strategies
Massachusetts
– -$1.99M -21,433 Closed
MIM
168
MetLife Investment Management
New Jersey
– -$1.98M -21,270 Closed
IBT
169
International Biotechnology Trust
United Kingdom
– -$1.95M -21,000 Closed
Tudor Investment Corp
170
Tudor Investment Corp
Connecticut
– -$1.94M -20,915 Closed
VI
171
Vestcor Inc
New Brunswick, Canada
– -$1.86M -20,000 Closed
WMSA
172
Weiss Multi-Strategy Advisers
New York
– -$1.7M -18,241 Closed
GGHC
173
Gilder Gagnon Howe & Co
New York
– -$1.63M -17,519 Closed
SMC
174
S. Muoio & Co
New York
– -$1.58M -17,000 Closed
RCG
175
Rock Creek Group
District of Columbia
– -$1.49M -16,205 Closed
5 6
7
8 9

ARNA Hedge Fund Activity: Q1 2022 in Review

1 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Arena Pharmaceuticals Inc (ARNA) for Q1 2022, worth a combined $0 — down 100% from $4.86B a quarter earlier.

Sellers outnumbered buyers: 312 funds closed out of ARNA and 0 opened new positions — a net loss of 312 holders — while 1 trimmed existing stakes and 0 added.

The largest seller was Vanguard Group, exiting entirely with an estimated $530M sold.

  • 1 institutional investor held Arena Pharmaceuticals Inc (ARNA) as of Q1 2022, down from 316 in Q4 2021.
  • Funds reported $0 of Arena Pharmaceuticals Inc stock for Q1 2022, down 100% quarter-over-quarter.
  • 0 funds opened new Arena Pharmaceuticals Inc positions in Q1 2022 and 312 closed out, a net change of -312 holders.
  • The largest Arena Pharmaceuticals Inc seller in Q1 2022 was Vanguard Group, an estimated $530M sold.

Based on aggregated 13F filings for Q1 2022.